Cogent Biosciences Announces Pricing of Concurrent Public Offerings of Common Stock and 1.625% Convertible Senior Notes Due 2031 WALTHAM, Mass. and BOULDER, Colo., Nov. 11, 2025 (GLOBE NEWSWIRE) -- Cogent Biosciences, Inc. (“Cogent”) (Nasdaq: COGT), a biotechnology company focused on developing precision therapies for genetically defined diseases, today announced the pricing of its previously announced underwritten public offering of 9,677,420 shares of its common stock at a public offering price of $31.00 per share (such offering, the “Equity Offering”) and its underwritten public offeri...
Willis and Rare partners to launch innovative insurance solution for fishers in the Philippines The parametric insurance will protect livelihoods of 14,200 small-scale fishers, the first of its kind in the country SINGAPORE, Nov. 11, 2025 (GLOBE NEWSWIRE) -- The Government of the Philippines, through the Bureau of Fisheries and Aquatic Resources (BFAR) and the Philippine Crop Insurance Corporation (PCIC), has partnered with global conservation organization Rare and Willis, a WTW business (NASDAQ: WTW), to launch the country’s first parametric insurance solution for small-scale fishers. ...
Tims China to Announce Third Quarter 2025 Financial Results on December 9, 2025 SHANGHAI and NEW YORK, Nov. 11, 2025 (GLOBE NEWSWIRE) -- TH International Limited (“Tims China” (Nasdaq: THCH)), the exclusive operator of Tim Hortons coffee shops in China, plans to release its third quarter financial results before the U.S. market opens on Tuesday, December 9, 2025, with a conference call to follow at 8:00 AM EST or 9:00 PM China Standard Time. The conference call will be webcast, and can be accessed on the company Investor Relations website at . Participants are kindly encouraged to pre-re...
Company Update | Siam Global House (GLOBAL TB/BUY/Bt6.20/Target: Bt9.50) The tone during GLOBAL’s Opportunity Day presentation was neutral. The company maintains its store expansion plan, and will add three new stores in 4Q25, bringing the total number to 96 in 2025. For 2026, it plans to open more than four new stores. Management expects 4Q25 gross margin to exceed 26%, similar to 3Q25. The sales contribution from house-brand products should remain close to 3Q25’s level of 27%. Maintain BUY wit...
Company Results | Tidlor Holdings (TIDLOR TB/HOLD/Bt20.80/Target: Bt22.00) TIDLOR posted 3Q25 net profit of Bt1.4b (+43% yoy, +9% qoq), marking a new high quarterly record. The results beat our and consensus forecasts by 8%. Asset quality improved qoq while credit cost decreased qoq. NPL ratio declined qoq. We expect to see an improvement in asset quality with the company’s focus on maintaining good asset quality. Maintain HOLD with a higher target price of Bt22.00.
Company Results | Indorama Ventures (IVL/BUY/Bt17.6/Target: Bt27.00) IVL reported 3Q25 core profit of Bt177m and a net loss of Bt818m, both in line with expectations. Core EBITDA fell 15% qoq and 35% yoy to US$279m, pressured by weaker PET spreads and scheduled PO/MTBE maintenance. We see a gradual recovery starting from 4Q25 and stronger 2026 earnings on spread improvement, tariff benefits, and lower energy costs, targeting EBITDA ~US$1.4b. The planned IPOs of Indovinya (IOD) and Indovida (Pack...
Company Results | GFPT (GFPT TB/BUY/Bt10.30/Target: Bt15.00) GFPT reported a 3Q25 core profit of Bt710m up 26% yoy and 7% qoq, primarily driven by a strong gross profit margin as the company benefitted from low raw material costs. The outlook for 4Q25 remains strong, supported by an expected improvement in export volume and low raw material costs. Maintain BUY on GFPT with a target price of Bt15.00.
Company Results | Bangkok Commercial Asset Management (BAM TB/BUY/Bt6.85/Target: Bt9.00) BAM posted a 3Q25 net profit of Bt184m, down 8% yoy and 86% qoq. The results are lower than our and consensus estimates by 60% and 33%, respectively. BAM recognised additional expected credit loss, which rose 207%, mainly from the provisions made for BAM’s purchase of debtor’s collateral assets from the Legal Execution Department and the provisions for the uncertainties arising from asset management. We main...
Company Results | Supalai (SPALI TB/HOLD/Bt15.90/Target: Bt16.10) SPALI reported 3Q25 earnings of Bt1.17b, down 41% yoy but up 6% qoq, outperforming our expectations primarily due to higher-than-anticipated other income. For 4Q25, presales should be supported by new project launches, while earnings are expected to remain broadly flat qoq but fall yoy due to a high base comparison. We remain cautious about its business outlook, given the backlog, aggressive promotional campaigns, and weak homebuy...
Company Results | Muangthai Capital (MTC TB/BUY/Bt39.75/Target: Bt52.00) MTC reported a 3Q25 net profit of Bt1.72b (+16% yoy, +5% qoq). The results are in line with our and market expectations. The company’s NPL ratio stabilised qoq in 3Q25. The loan portfolio grew 10% in 9M25, compared with its 2025 loan growth target of up to 15% yoy. Maintain BUY. Target price: Bt52.00. MTC is our top pick in the finance sector.
Company Results | CP Axtra (CPAXT TB/BUY/Bt20.00/Target: Bt24.00) 3Q25 earnings are weaker than our and consensus forecasts by 19% and 14% respectively, mainly due to the lower-than-expected gross margin. However, wholesale SSSG has seen an improvement since end-Oct 25, benefitting from the Half-Half Plus copayment scheme. Maintain BUY with a lower target price of Bt24.00 (previous: Bt26.00).
Company Results | Betagro (BTG TB/BUY/Bt16.70/Target: Bt20.00) Betagro’s 3Q25 core profit was reported at Bt1,180m (up 14% yoy, but down 54% qoq). The key pressure on 3Q25 earnings qoq was a lower gross margin due to softer swine prices. We observe an upward trend in domestic swine prices in Nov 25 and expect the trend to continue into 1H26. Upgrade to BUY with a higher target price of Bt20.00.
Top Stories Company Results | Betagro (BTG TB/BUY/Bt16.70/Target: Bt20.00) Betagro’s 3Q25 core profit was reported at Bt1,180m (up 14% yoy, but down 54% qoq). The key pressure on 3Q25 earnings qoq was a lower gross margin due to softer swine prices. We observe an upward trend in domestic swine prices in Nov 25 and expect the trend to continue into 1H26. Upgrade to BUY with a higher target price of Bt20.00. Company Results | CP Axtra (CPAXT TB/BUY/Bt20.00/Target: Bt24.00) 3Q25 earnings are we...
PyroGenesis Announces Third Quarter 2025 Results MONTREAL, Nov. 11, 2025 (GLOBE NEWSWIRE) -- PyroGenesis Inc. (“PyroGenesis”) (TSX:PYR) (OTCQX:PYRGF) (FRA:8PY1), the leader in ultra-high temperature processes & engineering innovation, and a plasma-based technology provider to heavy industry & defense, today announces its financial and operating results for the third quarter ended September 30, 2025. “This quarter introduced new opportunities while reinforcing the broadening appeal of some of our mainstay technologies,” said P. Peter Pascali, President and CEO of PyroGenesis Inc. “The $1....
Alkane Resources Limited: Q1 FY2026 Operating & Financial Results Webcast PERTH, Australia, Nov. 12, 2025 (GLOBE NEWSWIRE) -- Alkane Resources Limited (ASX: ALK; TSX: ALK; OTCQX: ALKEF) (‘Alkane’ or ‘the Company’) will release its Q1 FY2026 Operating Financial Results on 13 November 2025. Following this, the Managing Director & CEO, Mr Nic Earner, and CFO, Mr James Carter, will host a conference call and webcast to discuss these results. Details to participate are as follows: Date/Time:Canada 4:00pm EST, Thursday 13 November 2025 Australia 8:00am AEDT, Friday 14 November 2025 Confe...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.